Stockreport

Recursion Publishes Annual Environmental, Social and Governance Report

Recursion Pharmaceuticals, Inc. - Class A  (RXRX) 
PDF SALT LAKE CITY, March 26, 2024 (GLOBE NEWSWIRE) -- Recursion (Nasdaq: RXRX), a clinical stage TechBio company leading the space by decoding biology to industrialize dr [Read more]